9:13 a.m. ET, December 10, 2020 A key FDA panel meets at 9 a.m. ET to discuss authorizing Pfizer's vaccine. Here's what you need to know. From CNN's Maggie Fox A health worker in Hollywood, Florida, injects a person during clinical trials for a Pfizer coronavirus vaccine on September 9. Eva Marie Uzcategui/Bloomberg/Getty Images There's not much suspense going into Thursday's meeting of the US Food and Drug Administration's vaccine advisers, who will discuss emergency use authorization for Pfizer and BioNTech's coronavirus vaccine. The meeting will be held from 9 a.m. ET to 6 p.m. ET. The EUA is widely expected and has been telegraphed with unusual frankness from the top of the FDA on down. But, the FDA has promised to listen to the advice of its Vaccines and Related Biological Products Advisory Committee.